Table 1.
Baseline clinical and laboratory characteristics of the study population divided according to thrombus burden
| Low thrombus burden (n = 178) | High thrombus burden (n = 95) | p value | |
|---|---|---|---|
| Age (years) | 62.3 ± 13.2 | 62.0 ± 14.7 | 0.866* |
| Male sex, n (%) | 143 (80.3) | 77 (81.1) | 0.482† |
| Diabetes mellitus, n (%) | 56 (31.5) | 31 (32.6) | 0.716† |
| Hypertension, n (%) | 106 (59.6) | 57 (60.0) | 0.503† |
| Hyperlipidemia, n (%) | 109 (61.2) | 65 (68.4) | 0.395† |
| Active smokers, n (%) | 75 (42.1) | 47 (49.5) | 0.200† |
| Prior MI, n (%) | 6 (3.4) | 3 (3.2) | 0.145† |
| LVEF (%) | 53.4 ± 9.7 | 52.9 ± 8.5 | 0.699* |
| Creatinine, µmol/L | 76.9 ± 24.5 | 81.4 ± 25.6 | 0.167* |
| Peak cTnI (ng/mL) | 29.8 (1.2-86.6) | 56.7 (16.4-100.6) | 0.037‡ |
*
Independent samples t-test;
†
Chi-square test;
‡
Mann-Whitney U test; MI: myocardial infarction; LVEF: left ventricular ejection fraction; cTnI: cardiac troponin I.